IFNG and neoplasm: Weight changes (Figure 6C) and tumor growth inhibition rates (Figures 6D, E) further validated these trends, with the IFN-γ + BMSC + QSFZYL group showing significant reductions in body weight and enhanced inhibition rates compared to other groups (P< 0.05).